Income tax expense · 2011–2025
Ligand Pharmaceuticals income tax expense
$34.5M+426.8% · FY2025
Ligand Pharmaceuticals (LGND) reported $34.5M in income tax expense for fiscal 2025, +426.8% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $34.5M | +426.8% | Open → |
| FY20242024-12-31 | $6.6M | −33.4% | Open → |
| FY20232023-12-31 | $9.8M | −76.1% | Open → |
| FY20222022-12-31 | $41.2M | +$45.4M | Open → |
| FY20212021-12-31 | −$4.1M | +$1.2M | Open → |
| FY20202020-12-31 | −$5.3M | −$173M | Open → |
| FY20192019-12-31 | $167M | +457.6% | Open → |
| FY20182018-12-31 | $30.0M | −32.8% | Open → |
| FY20172017-12-31 | $44.7M | +332.6% | Open → |
| FY20162016-12-31 | $10.3M | +$202M | Open → |
| FY20152015-12-31 | −$192M | −$193M | Open → |
| FY20142014-12-31 | $410,000 | +9.6% | Open → |
| FY20132013-12-31 | $374,000 | +$1.6M | Open → |
| FY20122012-12-31 | −$1.2M | +$12.1M | Open → |
| FY20112011-12-31 | −$13.3M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ligand Pharmaceuticals income tax expense |url=https://companiesranked.com/en/company/ligand-pharmaceuticals/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ligand Pharmaceuticals income tax expense. CompaniesRanked. https://companiesranked.com/en/company/ligand-pharmaceuticals/income-tax-expenseBibTeX
@misc{companiesranked-en-company-ligand-pharmaceuticals-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Ligand Pharmaceuticals income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ligand-pharmaceuticals/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000886163-26-000006 · February 27, 2026
{{cite web |title=Ligand Pharmaceuticals income tax expense — 10-K (0000886163-26-000006) |url=https://www.sec.gov/Archives/edgar/data/886163/000088616326000006/lgnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.